Biomaterial Clinical Performance in a Socket Preservation Model
Comparative Clinical Performance of Biphasic Calcium Sulfate Cement Matrix With Hydroxyapatite Granules in a Socket Preservation Model: a Pilot Clinical Trial Parallel Group Assignment
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
When a dental extraction is performed, sequential cascade of events happens that lead to a modeling and remodeling of the area. This phenomenon leads to bone resorption and consequential volume loss atrophy. In literature several biomaterials (Autogenous, alloplastic, allografts and xenografts) were tested as alveolar fillers with the aim of controlling this physiologic event. Socket preservation is today a very widely spread dental technic to preserve the alveolar dimensions, that uses a wide range of biomaterials. Alloplastic materials have a fair evidence to work in several regenerative procedures in the oral and maxillofacial region. This pilot trial aims to characterize Histologic bone healing pattern in a human socket preservation model of 2/3 biphasic calcium sulfate cement matrix's and Hydroxyapatite (HA granules). Alterations in Volumetric alveolar socket changes in a socket preservation clinical model will also be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2021
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedMarch 10, 2021
March 1, 2021
1 year
February 13, 2021
March 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Histologic Examination Histomorphometric Analysis
Histologic measure, percentage of Vital Bone formation, Fibrous/connective tissue, and material remnant present in the sample.
3 month after tooth extraction
Secondary Outcomes (7)
Volumetric Changes Clinical
at pre-extraction and at final crown insertion up to 1 year
Radiographic CBCT - Bone evaluation
at pre-extraction and at final crown insertion up to 1 year
Primary and Secondary stability
at implant placement and at dental crown insertion up to 1 year
Incidence of Implant Success rate
at final treatment (crown insertion) up to 1 year
Implant probing depth
At implant insertion and At final treatment (crown insertion) up to 1 year
- +2 more secondary outcomes
Study Arms (2)
Socket Preservation Alloplastic Material
EXPERIMENTAL10 Consecutive Patients with hopeless teeth and 1/3 or more buccal bone resorption will be placed in a therapy go bone regeneration called socket preservation technique. The surgery will include placement of 2/3 biphasic calcium sulfate cement matrix's with hydroxyapatite (HA granules) to fill the alveolar defects, and place a resorbable membrane sutured to adjacent tissue, to avoid material leakage. No flap retraction. 3 Month later an implant will be placed, and a bone biopsy of the healed socket harvested. 2 Month later a final Zirconia ceramic crown screw retained to the osseointegrated implant. Primary (T0) and Secondary (T1) stability measured with ISQ values. Intraoral Scanner and an STL File will be taken at T0 , T1 and T2 for volumetric alteration evaluation.
Extraction Socket Spontaneous Healing
ACTIVE COMPARATOR10 Consecutive patients with a tooth extraction without the aim of placing a future implant and without Biomaterial filler placed in the socket. Spontaneous healing
Interventions
Pre-op CBCT scanner for evaluating bone conditions around hopeless tooth. If 1/3 of the buccal plate is missing, considered a class 2 alveolar socket. Extraction of tooth and place 2/3 biphasic calcium sulfate cement matrix's with Hydroxyapatite (HA granules) , condensed , and covered with a resorbable membrane suture to the adjacent tissue. At implant placement ,take bone for histological preparation and histomorphometric analysis of the healing pattern. At T0, T1 and T2 measure adjacent teeth periodontal status , Probing Depth , bleeding on probing. Volumetric measurements, will use fixed landmarks (ex. adjacent teeth) to calibrate the STL measurements. Calculate the difference between pre-extraction socket and the post treatment with the alloplastic material. Primary and secondary stability will be measured by ISQ units with a RFA machine, that will include the machine to measure and the magnetic tip to be screwed in the implant platform.
Pre-op CBCT scanner for evaluating bone conditions around hopeless tooth, at extraction day, no flap opening , atraumatic extraction, no biomaterial filler, At T0, T2 measure adjacent teeth periodontal status , Probing Depth , bleeding on probing. Volumetric measurements will include an intramural scanner from all the stages , we will use fixed landmarks (ex. adjacent teeth) to calibrate the STL measurements. Calculate the difference between pre-extraction socket and the post treatment with the alloplastic material.
Eligibility Criteria
You may qualify if:
- Aged 18 or over
- requiring extraction of teeth in the premolar region and anterior maxilla (15-25), presence of intact 2/3 or less, buccal bone plate
- ASA (Physical Status Classification System, American Society of Anesthesiologist) I or II.
You may not qualify if:
- patients with uncompensated systemic diseases, metabolic and healing disorders, i.e. diabetes mellitus, hyperparathyroidism, cancer, HIV,
- heavy smokers (\>5 cigarettes/ day),
- bone metabolic diseases,
- severe renal dysfunction or liver disease,
- had received systemic corticosteroids or other immunosuppressive agents, radiation therapy and/or chemotherapy for the past 2 months,
- active infections in the surgical site
- patients with periodontal or/and endodontic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andre Chen, Phd
International Advanced Dentistry
- STUDY DIRECTOR
João Borges, Msc
International Advanced Dentistry
- STUDY CHAIR
Elena Cervino, Msc
International Advanced Dentistry
- STUDY CHAIR
Amos Yahav, DMD
Augma Bio
- STUDY CHAIR
Ofir Yahav, DMD
Augma Bio
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Person who does the volumetric analysis is blinded, Person who makes data treatment is blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2021
First Posted
March 10, 2021
Study Start
May 1, 2021
Primary Completion
May 1, 2022
Study Completion
August 1, 2022
Last Updated
March 10, 2021
Record last verified: 2021-03